RE:Just Wondering IIAgree DF more details would be appreciated but my take is this NR isn't for investors. Feels like it's more tactical, not to be patronizing but I think about it like buying a home. If it's a slow market and you know you're the only one looking, you are going to sit back and think about it. If the realtor tells you there is alot of interest and potential offers you're not going to waste time. In reality we might be able to get more value at later stages in the trial but if there are multiple interested parties it will be forward looking and once a tipping point is reached where greed outweighs risk you could easily see a buyout or licensing deal for valuations that would be more appropriate for the later stages. Looking at preclinical companies like semma. That was a very forward looking acquisition. Feels like anything is possible at this stage in the game. Heading into a cell therapy revolution there is likely to be some aggressive acquisitions.